Coronavirus vaccine: from Australia to Malaysia, here’s where Asia stands on the Pfizer shot

The quick approval of Pfizer’s coronavirus vaccine in the UK isn’t likely to accelerate the availability of the shot in Asia, as countries work to complete local safety tests and negotiate deals.Asia’s biggest economies including China and Japan still need to finish local trials to demonstrate the Pfizer shot is safe, and even then, most countries have set deliveries for next year. In addition, some developing countries in Asia with the biggest outbreaks don’t have deals with Pfizer, and lack…

Read the original article at South China Morning Post